Implementation of a Delirium Assessment Tool in the ICU Can Influence Haloperidol Use
Mark van den Boogaard, Peter Pickkers, Hans van der Hoeven, Gabriel Roodbol, Theo van Achterberg, Lisette Schoonhoven.
Critical Care 2009, 13:R131
Introduction: In critically ill patients, delirium is a serious and frequent disorder associated with a prolonged intensive care and hospital stay and an increased morbidity and mortality. Without using a delirium screening instrument, delirium is often missed by ICU-nurses and physicians. The effects of implementation of a screening method on haloperidol use is not known. The purpose of this study was to evaluate the implementation of the confusion assessment method-ICU (CAM ICU) and the effect of its use on frequency and duration of haloperidol use.
Methods: We used a tailored implementation strategy focused on potential barriers. We measured CAM-ICU compliance, interrater reliability, delirium knowledge and compared the haloperidol use, as a proxy for delirium incidence, before and after the implementation of the CAM-ICU.
Results: Compliance and delirium knowledge increased from 77% to 92% and from 6.2 to 7.4, respectively (both, p<0.0001). The interrater reliability increased from 0.78 to 0.89. More patients were treated with haloperidol (9.9% to 14.8%, p<0.001), however with a lower dose (18 to 6mg/patient, p=0.01) and for a shorter time period (5 [IQR:2-9] to 3 [IQR:1-5] days, p=0.02).
Conclusions: With a tailored implementation strategy, a delirium assessment tool was successfully introduced in the ICU with the main goals achieved within four months. Early detection of delirium in critically ill patients increases the number of patients that receive treatment with haloperidol, however with a lower dose and for a shorter time period.
A new frontier in critical care: saving the injuried brain.
Gestire il doloreFlowchart dolore
Gestire la sedazioneFlowchart sedaz/agitaz
Gestire il deliriumFlowchart Delirium
Scheda di lavoro CAM-ICU
Questo sito è stato realizzato grazie al contributo di:
Finanziamento per la Ricerca Indipendente
(Decreto DGS 13456 del 22 dicembre 2010)